Biopharmaceutical company developing innovative botanical drugs for addiction treatment.
About
NFL Biosciences develops botanical drugs to treat addictions, focusing on tobacco, alcohol, and cannabis. Their pipeline includes innovative drug candidates like NFL-101 and NFL-102 for smoking cessation, and NFL-301 for excessive alcohol consumption, aiming to license these to pharmaceutical laboratories. The company leverages scientific expertise in botanical medicines and conducts preclinical and clinical studies.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
10Traction
36Team
30Visibility
6Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does NFL Biosciences do?
NFL Biosciences develops botanical drugs to treat addictions, focusing on tobacco, alcohol, and cannabis. Their pipeline includes innovative drug candidates like NFL-101 and NFL-102 for smoking cessation, and NFL-301 for excessive alcohol consumption, aiming to license these to pharmaceutical laboratories. The company leverages scientific expertise in botanical medicines and conducts preclinical and clinical studies. (formerly [].)
How much funding has NFL Biosciences raised?
NFL Biosciences has raised a total of $16M in funding. The most recent round on record is Bond Financing.
Where is NFL Biosciences headquartered?
NFL Biosciences is headquartered in Castelnau-le-Lez, France.
When was NFL Biosciences founded?
NFL Biosciences was founded in 2001.
What industry does NFL Biosciences operate in?
NFL Biosciences operates in Biotechnology, Pharmaceuticals, Healthcare.
What is NFL Biosciences's current status?
NFL Biosciences's current operating status is: Public.